RDTCF (Rapid Dose Therapeutics) Price-to-Free-Cash-Flow : N/A (As of Mar. 02, 2025)

View and export this data going back to 2019. Start your Free Trial

What is Rapid Dose Therapeutics Price-to-Free-Cash-Flow?

As of today (2025-03-02), Rapid Dose Therapeutics's share price is $0.18. Rapid Dose Therapeutics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Nov. 2024 was $-0.02. Hence, Rapid Dose Therapeutics's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Rapid Dose Therapeutics's Price-to-Free-Cash-Flow or its related term are showing as below:

RDTCF's Price-to-Free-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 34.19
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Rapid Dose Therapeutics's Free Cash Flow per Share for the three months ended in Nov. 2024 was $-0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-0.02.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -1.60% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 26.10% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 20.00% per year.

During the past 13 years, Rapid Dose Therapeutics's highest 3-Year average Free Cash Flow per Share Growth Rate was 47.70% per year. The lowest was -20.90% per year. And the median was 7.30% per year.

Rapid Dose Therapeutics Price-to-Free-Cash-Flow Historical Data

The historical data trend for Rapid Dose Therapeutics's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Price-to-Free-Cash-Flow Chart

Rapid Dose Therapeutics Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Price-to-Free-Cash-Flow

Get a 7-Day Free Trial

Rapid Dose Therapeutics Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Price-to-Free-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Rapid Dose Therapeutics's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Rapid Dose Therapeutics's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rapid Dose Therapeutics's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's Price-to-Free-Cash-Flow falls into.

Rapid Dose Therapeutics Price-to-Free-Cash-Flow Calculation

Rapid Dose Therapeutics's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio	=	Share Price	/	Free Cash Flow per Share (TTM)
	=	0.18	/	-0.017
	=	N/A

Rapid Dose Therapeutics's Share Price of today is $0.18.
Rapid Dose Therapeutics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio

Market Cap

Free Cash Flow

Rapid Dose Therapeutics (OTCPK:RDTCF) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

Rapid Dose Therapeutics Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Dose Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (OTCPK:RDTCF) » Definitions » Price-to-Free-Cash-Flow

Comparable Companies

Traded in Other Exchanges

DOSE:Canada

Address

1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4

Website

https://www.rapid-dose.com

Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.